Dynamic Technology Lab Private Ltd Takes $322,000 Position in Oscar Health, Inc. $OSCR

Key Points

• Dynamic Technology Lab Private Ltd has made a significant investment in Oscar Health, acquiring 24,569 shares valued at approximately $322,000 during the first quarter.
• Oscar Health’s shares recently traded at $19.33, with a 52-week low of $11.20 and a high of $23.79, while the company's stock has a consensus rating of "Strong Sell" from analysts.
• The company reported a quarterly revenue of $2.86 billion, a 29% increase year-over-year, but posted a loss of $0.89 earnings per share, slightly better than analysts' expectations.

Dynamic Technology Lab Private Ltd acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 24,569 shares of the company's stock, valued at approximately $322,000.

Several other large investors have also recently added to or reduced their stakes in OSCR. Nuveen LLC bought a new position in Oscar Health during the first quarter worth $29,684,000. Thrive Capital Management LLC lifted its stake in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after purchasing an additional 1,588,395 shares during the last quarter. Man Group plc lifted its stake in Oscar Health by 344.8% during the fourth quarter. Man Group plc now owns 1,813,216 shares of the company's stock worth $24,370,000 after purchasing an additional 1,405,554 shares during the last quarter. Southeastern Asset Management Inc. TN lifted its stake in Oscar Health by 52.2% during the fourth quarter. Southeastern Asset Management Inc. TN now owns 3,131,084 shares of the company's stock worth $42,082,000 after purchasing an additional 1,073,359 shares during the last quarter. Finally, Ameriprise Financial Inc. lifted its stake in Oscar Health by 3,062.3% during the fourth quarter. Ameriprise Financial Inc. now owns 976,563 shares of the company's stock worth $13,125,000 after purchasing an additional 945,682 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors.

Oscar Health Price Performance

Shares of NYSE OSCR opened at $19.33 on Friday. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.79. The firm's 50-day simple moving average is $15.92 and its 200 day simple moving average is $15.15. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The stock has a market cap of $5.00 billion, a P/E ratio of -23.86 and a beta of 1.87.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, beating analysts' consensus estimates of ($0.90) by $0.01. Oscar Health had a negative net margin of 1.50% and a negative return on equity of 13.78%. The business had revenue of $2.86 billion for the quarter, compared to analysts' expectations of $2.88 billion. During the same period in the previous year, the business earned $0.20 earnings per share. The company's revenue was up 29.0% on a year-over-year basis. Equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

OSCR has been the topic of several research analyst reports. Wells Fargo & Company cut Oscar Health from an "equal weight" rating to an "underweight" rating and reduced their price objective for the stock from $16.00 to $10.00 in a research note on Friday, July 11th. Wall Street Zen cut Oscar Health from a "hold" rating to a "sell" rating in a research note on Saturday, August 9th. Raymond James Financial cut Oscar Health from an "outperform" rating to a "market perform" rating in a research note on Tuesday, June 24th. Baird R W cut Oscar Health from a "strong-buy" rating to a "hold" rating in a research note on Friday, July 25th. Finally, Barclays cut their target price on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a research note on Wednesday, July 23rd. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Strong Sell" and a consensus price target of $12.07.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.